Responses to parliamentary questions
Question from Deputy Pádraig O'Sullivan - PQ 46536-26
Deputy O'Sullivan asked if daraxonrasib is available for the treatment of patients with pancreatic cancer in Ireland. Read the HSE response.
From: Communications and Public Affairs
Published: June 2026
Updated: July 2026
Documents
Summary
To ask the Minister for Health whether the medicine daraxonrasib is available for the treatment of patients with pancreatic cancer in Ireland; whether it is or will be eligible for reimbursement by the HSE; and if she will make a statement on the matter.
This is a beta version - your feedback will help us to improve it